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I n t r o d u c t i o n  
Rest r ic t ion  of d ie ta ry  pro te in  in take  is wide ly  used  for  conse rva t ive  
t r e a t m e n t  of chronic  renal  failure. Severe ly  pro te in- res t r ic ted  diets,  such  
as the  spaghet t i -egg  diet  (1), or the  po ta to-egg  diet  (2), have  b e e n  assoc ia ted  
wi th  indica t ions  for  p ro te in  def ic iency  such  as we igh t  loss, acidosis,  
musc l e  a t rophy ,  nega t ive  n i t rogen  ba l ance  and  dec rease  of s e r u m  pro te ins  
(3-7). A t t e m p t s  to i m p r o v e  these  diets  b y  addi t ion  of amino  acids  have  not  
a l tered the  re luc tance  of pa t i en t s  to fol low such  m o n o t o n o u s  d ie tary  
r eg imens  (8). To  ach ieve  a pos i t ive  n i t rogen  balance,  the  Sweden-d ie t  
conta in ing  18 g p ro te in /day  requ i red  oral  s u p p l e m e n t a t i o n  wi th  16.6 g 
essent ia l  a m i n o  acids (EAA) (9, 10). However ,  this  diet  was  difficult  to 
app ly  s ince it r equ i red  initial hospi ta l iza t ion  and  re -admiss ion  w h e n e v e r  
d ie ta ry  c o m p l i a n c e  was  inadequate .  
K o p p l e  et al. (11) ach ieved  n i t rogen  ba lance  and  low s y m p t o m a t o l o g y  
wi th  a diet  of 0.6 g h igh  biological  va lue  pro te in  pe r  kg  b o d y  we igh t  in 
pa t i en t s  wi th  pro- te rmina l  renal  fai lure (mean  G F R  = 5.1 ml/min) .  In  
con t ras t  to the  lower  p ro te in  diets,  the  40-g-protein die t  was  sub jec t ive ly  
well  to lera ted  and  p re fe r r ed  b y  pa t ien ts  (12). 
Benef ic ia l  effects  of EAA s u p p l e m e n t a t i o n  h a v e  been  r epor t ed  by  
severa l  g roups  par t icu lar ly  for  severe ly  p ro te in - res t r i c ted  diets.  G lomeru-  
lar  f i l t rat ion rate, b lood  u rea  n i t rogen  (BUN), u r emic  s y m p t o m a t o l o g y ,  
and  n i t rogen  ba lance  would  i m p r o v e  wi th  EAA (10, 13-16) or wi th  a lpha  
ke to -ana logues  (a-K/k) (17-19). However ,  the  p r o p o s e d  n i t rogen-spar ing  
effect  of EAA t h r o u g h  recycl ing  of u rea  has  r ecen t ly  been  cha l lenged  (20). 
Walser  et al. (21) sugges t ed  tha t  a -KA i nduced  specif ic  me tabo l i c  effects,  
wh ich  were  unre la ted  to the  h igher  d ie ta ry  p ro te in  equ iva len t  bu t  s h o w e d  
the  super ior i ty  of a -KA over  EAA only in few pat ients .  S tudies  by  Burns  et  
al. (22) c o m p a r e d  EAA and  a -KA s u p p l e m e n t a t i o n  in renal  fa i lure  pa t ien ts  
on 29-49-g-protein diets  and  could  not  s u p p o r t  any  super io r i ty  of r 
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Simi la r ly ,  G i o r d a n o  (23) c o u l d  n o t  f i n d  a n y  a d v a n t a g e  of a - K A  over  E A A  in  
r e n a l  fai lure.  
F o r  t he  m o r e  p a l a t a b l e  40-g-pro te in  diet ,  Y o u n g  et  al. (24) h a v e  s h o w n  
a n  i m p r o v e m e n t  of t h e  l ow  s e r u m - c o m p l e m e n t  C3 f r ac t i on  a n d  t r a n s f e r r i n  
u s i n g  E A A  s u p p l e m e n t a t i o n .  S o m e  c e n t e r s  h a v e  e v e n  s u p p l e m e n t e d  t he  
70-g-pro te in  d ie t  i n  h e m o d i a l y s i s  p a t i e n t s  w i t h  E A A  or a -KA,  b u t  ou r  o w n  
s t u d i e s  (25) s h o w e d  n o  p rof i t  i n  th i s  se t t ing .  
T h e  p u r p o s e  of th i s  s t u d y  was  to d e t e r m i n e  if b e n e f i c i a l  effects  of E A A  
or  a - K A  s u p p l e m e n t a t i o n  o c c u r  i n  p a t i e n t s  m a i n t a i n e d  o n  th i s  m o r e  
p a l a t a b l e  p r o t e i n  d ie t  of 40 g /day  r a t h e r  t h a n  w i t h  t he  p r e v i o u s l y  s t u d i e d  
b u t  p o o r l y  a c c e p t e d  d i e t a ry  r e s t r i c t i o n  to a p p r o x i m a t e l y  20 g p r o t e i n / d a y .  
To a l low p rac t i c a l  a p p l i c a t i o n ,  t he  l o n g - t e r m  effects  of a n y  d i e t a r y  r e g i m e n  
h a v e  to b e  e v a l u a t e d  in  o u t p a t i e n t s ,  ye t  u n d e r  s u c h  c o n d i t i o n s  c l i n i ca l ly  
c o n t r o l l e d  s t u d i e s  h a v e  b e e n  scarce .  We, the re fore ,  e v a l u a t e d  t he  ef fec t  of 
s u p p l e m e n t a t i o n  w i t h  E A A  a n d  w i t h  a - K A  o n  the  u r e m i c ,  n u t r i t i o n a l ,  a n d  
p r o t e i n  s t a tus  a n d  o n  r e s i d u a l  r e n a l  f u n c t i o n  i n  a m b u l a t o r y  p a t i e n t s  w i t h  
a d v a n c e d  r e n a l  f a i lu re  on  a m o d e r a t e l y  r e s t r i c t ed  p r o t e i n  i n t ake .  
P a t i e n t s  and m e t h o d s  
32 patients with chronic renal failure entered this study. However, 17 patients 
had to be excluded before entering the therapeutic period, because 5 required 
hemodialysis and 12 refused to cont inue on the strict dietary protocol. Data for the 
remaining 15 patients who completed this study are listed in table 1. 
All patients were instructed in a mixed diet according to Schmidt-Deutsch- 
Kriehuber (26) containing 0.57 g protein/kg body weight (40 g for 70-kg-patient). 
Every 3 weeks, clinical, biochemical and anthropometric data were obtained and 
dietary instructions re-inforced. Dietary questionnaires were performed every 
6 weeks. 
Table 1. Patient data. 
S. creatinine 
Age Sex Weight initial final Diagnosis 
(kg) (~mole/liter) 
DG 22 f 66 601 681 
GH 36 f 45 469 513 
GF 55 f 52 566 672 
GB 52 f 55 486 637 
PM 51 m 82 760 796 
SH 51 m 97 601 663 
WU 43 f 56 460 460 
HP 16 f 45 628 681 
JC 45 m 65 486 813 
KG 48 m 71 583 698 
KK 53 m 70 698 884 
KI-I 60 m 86 407 407 
ML 41 f 51 460 530 
SA 31 f 56 530 451 
















mean+_SD 43.7+_12.6 65.7+_16.5 551_+97 625_+144 
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Tab le  2. C o n t e n t s  of EAA-granules. Dai ly  d o s e  for  70-kg pa t ien t .  
L- I so leuc ine  0.76 g 
L-Leuc ine  1.20 g 
L -Meth ion ine  1.20 g 
n - P h e n y l a l a n i n e  1.20 g 
L-Valine 0.87 g 
L-His t id ine  0.60 g 
L-Lysine  1.23 g 
L -Thr eon i ne  0.54 g 
L - T r y p t o p h a n e  0.27 g 
Total :  7.87 g 
T a b l e  3. C o n t e n t s  of a -KA-granu les .  Dai ly  d o s e  for  70-kg pa t i en t .  
K A  of I s o l e u c i n e  1.22 g 
K A  of L e u c i n e  1.52 g 
K A  of M e t h i o n i n e  0.93 g 
K A  of P h e n y l a l a n i n e  0.85 g 
K A  of V a l i n e  1.58 g 
L-His t id ine  0.27 g 
L-Lysine  0.45 g 
L -Thr eon i ne  0.34 g 
L - T r y p t o p h a n e  0.17 g 
Total :  7.33 g 
Af te r  a b a s e l i n e  p e r i o d  of 6 w e e k s  o n  t he  d e s c r i b e d  d i e t  w i t h o u t  s u p p l e m e n t a -  
t ion,  all  p a t i e n t s  i nges t ed ,  in  a d d i t i o n  to  t h e  diet ,  da i ly  0.112 g of a n  E A A  m i x t u r e / k g  
b o d y  w e i g h t  o v e r  6 w e e k s  as s h o w n  in  t ab l e  2. T h i s  was  fo l lowed  b y  a 6 -week  
d o u b l e - b l i n d  c ros s -ove r  s t u d y  in  w h i c h  7 p a t i e n t s  r e c e i v e d  oral ly  0.105 g of a n  a -KA 
m i x t u r e / k g  b o d y  we igh t ,  fo l lowed  b y  6 w e e k s  of p lacebo ,  w h i l e  6 p a t i e n t s  r e c e i v e d  
p l a c e b o  f i rs t  fo l lowed  b y  a -KA for  6 w e e k s  each .  T h e  a -KA c o n s i s t e d  of 5 ke to-  
a n a l o g u e s  of e s sen t i a l  a m i n o  ac id s  p l u s  t h e  r e m a i n i n g  3 e s sen t i a l  a m i n o  ac ids  a n d  
h i s t i d i n e  as  s h o w n  in  t ab l e  3. T h e  d o s e  of E A A  a n d  a -KA was  a d j u s t e d  in  incre-  
m e n t s  p e r  10 k g  b o d y  w e i g h t  u s i n g  p a t i e n t ' s  w e i g h t  to  t h e  n e a r e s t  10 kg. T h e  
p l a c e b o  c o n t a i n e d  t h e  s a m e  v e h i c l e  b u t  n o  a-KA1). T h e  E A A  m i x t u r e  s u p p l i e d  1.15 
of t h e  m i n i m u m  dai ly  r e q u i r e m e n t  for  n o n - u r e m i c  p a t i e n t s  a c c o r d i n g  to  R o s e  (27) in 
a d d i t i o n  to t h e  p r o t e i n  in take .  T h e  a -KA m i x t u r e  is c o m m e r c i a l l y  ava i l ab l e  a n d  ha s  
s imi l a r  c o m p o s i t i o n  ( tab le  3). Al l  p a t i e n t s  e n t e r e d  t h e  s t u d y  a f te r  g iv ing  i n f o r m e d  
c o n s e n t  r e g a r d i n g  p u r p o s e  a n d  r i sk s  of t h e  i nves t iga t ion .  L o n g - t e r m  m e d i c a t i o n s  
s u c h  as  a n t i h y p e r t e n s i v e s ,  a l u m i n u m  h y d r o x i d e ,  f u r o s e m i d e  a n d  c a l c i u m  sa l t s  
w e r e  m a i n t a i n e d  w i t h  occas iona l  a d j u s t m e n t s  a c c o r d i n g  to c l in ica l  i nd ica t ions .  
T h r o u g h o u t  t h i s  s t u d y  all  p a t i e n t s  r e c e i v e d  daffy ora l  i r on  a n d  m u l t i - v i t a m i n  
s u b s t i t u t i o n ,  w h i c h  h a d  b e e n  s t a r t e d  at  l eas t  one  m o n t h  p r io r  to  t h e  b a s e l i n e  per iod .  
Cl in ica l  da ta :  P a t i e n t s  h a d  a phys i ca l  e x a m i n a t i o n  e v e r y  3 weeks ,  a t  w h i c h  t i m e  
t h e  leve l  of p h y s i c a l  a n d  m e n t a l  ac t iv i ty ,  appe t i t e ,  a n d  t h e  p r e s e n c e  of nausea ,  
v o m i t i n g  a n d  e d e m a  w e r e  r eco rded .  M e a s u r e m e n t s  of b o d y  weigh t ,  t r i c eps  sk in fo ld  
t h i c k n e s s  b y  u s e  of t h e  L a n g e  ca l ipe r  (28), a n d  u p p e r  a r m  c i r c u m f e r e n c e  w e r e  
o b t a i n e d  b i l a t e ra l ly  a n d  t h e  m u s c l e / f a t  ra t io  was  d e r i v e d  f r o m  t h e s e  data .  
1) G r a n u l e s  c o n t a i n i n g  a -KA or  p l a c e b o  w e r e  k i n d l y  s u p p l i e d  b y  P f r i m m e r  Inc. ,  
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D i e t a r y  c o m p l i a n c e :  P a t i e n t s  a n d  t h e i r  s p o u s e s  w e r e  a d v i s e d  e v e r y  3 w e e k s  
r e g a r d i n g  t h e i r  p r e s c r i b e d  diet .  E v e r y  6 w e e k s  t he  p a t i e n t s  r eco rded ,  for  s e v e n  
days ,  t h e  w e i g h e d  food  i n t a k e  o n  d e t a i l e d  q u e s t i o n n a i r e s .  F r o m  t h e s e  da t a  t h e  
a m o u n t  of to t a l  p r o t e i n  in take ,  t h e  p r o p o r t i o n  of h i g h  b io log ica l  v a l u e  p r o t e i n  a n d  
t h e  ca lor ic  i n t a k e  w e r e  c a l c u l a t e d  b y  u s e  of food  tab les .  
B i o c h e m i c a l  data:  E v e r y  3 w e e k s  f a s t i ng  v e n o u s  b l o o d  s a m p l e s  w e r e  d r a w n  
b e t w e e n  7 a n d  9 a.m. for  i m m e d i a t e  ana lys i s  u s i n g  s t a n d a r d  t e c h n i q u e s .  T h e  
ana lys i s  of t h e  c o m p l e m e n t  c o m p o n e n t s  was  p e r f o r m e d  a f t e r  s t o r age  of t h e  s e r u m  
a t  - 7 0  ~ T h e  b i o c h e m i c a l  p a r a m e t e r s  i n v e s t i g a t e d  a re  l i s t ed  in  t ab l e  4. 
S ta t i s t i ca l  ana lys is :  T h e  p a i r e d  S t u d e n t ' s  t - t e s t  was  u s e d  for  c o m p a r i s o n  of 
m e a n s .  D a t a  co l l ec ted  at  3 w e e k s  a n d  a t  t h e  e n d  of e a c h  p e r i o d  as wel l  as m e a n  da t a  
for  e a c h  p e r i o d  w e r e  c o m p a r e d .  T h e  s a m e  t e s t  w as  u s e d  for  ana lys i s  of s u b g r o u p s  
w i t h  h i g h e r  a n d  lower  p r o t e i n  in takes .  Cl in ica l  a n d  b i o c h e m i c a l  p a r a m e t e r s  w e r e  
a lso t e s t e d  for  s i gn i f i c a n t  c o r r e l a t i o n  in  e a c h  p e r i o d  b y  a p p l i c a t i o n  of l i n e a r  regres-  
s ion  e q u a t i o n s .  T h e  l imi t s  of  s i g n i f i c a n c e  w e r e  c h o s e n  for  t h e  t w o - s i d e d  t e s t  as 
p < 0.05. 
R e s u l t s  
Physical  findings: Within the different s tudy periods, blood pressure, 
signs of edema, and state of health did not  change, and the increasing 
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Fig. 1. A n t h r o p o m e t r i c  p a r a m e t e r s  d u r i n g  d i f f e ren t  s t u d y  per iods .  S u p p l e m e n t a -  
t i on  w i t h  e s sen t i a l  a m i n o  ac ids  or  a -ke to  ac ids  c a u s e s  n o  i m p r o v e m e n t  in  a n y  of 
t h e s e  p a r a m e t e r s .  
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Fig. 2. A v e r a g e  p r o t e i n  i n t ake ,  a c c o r d i n g  to  d i e t a r y  q u e s t i o n n a i r e s ,  w i t h  a d d i t i o n a l  
i n t a k e  of e s sen t i a l  a m i n o  ac ids  (EAA) or  a -ke to  ac ids  (KETO) for  e a c h  per iod .  T h e  
a -ke to  ac ids  a re  c o n s i d e r e d  h e r e  as t r a n s f o r m e d  to a m i n o  acids .  
ca lc ium salts  w e r e  no t  s ignif icant ly  d i f ferent  for  each  period.  Clinical  
compl ica t ions  of s u p p l e m e n t a l  t h e r a p y  could  no t  be  detected.  
A n t h r o p o m e t r i c  data: As s h o w n  in f igure 1, b o d y  weight ,  u p p e r  a r m  
c i r cumfe rence  as well  as the  musc le / f a t  rat io  did not  change  s ignif icant ly  
du r ing  the  d i f ferent  t he rapeu t i c  phases .  The  r educ t ion  in sk info ld  th ick-  
ness  dur ing  a -KA was  s ignif icant  b u t  was  the  s ame  as dur ing  p lacebo  
supp l emen ta t i on .  
Die ta ry  control:  The  daily p ro te in  in take  ave raged  0.528-0.571 g /kg  
b o d y  we igh t  (37-40 g/70 kg), w i th  an ima l  p ro te in  accoun t ing  for  50-56 %. 
The  daily caloric in take  was  26.4 to 28.2 kca l / body  we igh t  (1848 to 
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Fig. 3. I n d i v i d u a l  d i e t a ry  p r o t e i n  i n t a k e  a c c o r d i n g  to  7-day r eco rd ings .  T h e  addi -  
t i ona l  i n t a k e  of e s sen t i a l  a m i n o  ac ids  or  a -ke to  ac ids  is no t  cons ide r ed .  
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Fig. 4. T h e  G F R  as c r e a t i n i n e  c l e a r a n c e  is n o t  a m e l i o r a t e d  b y  t h e r a p y .  T h e  l o w e r  
p a n e l  s h o w s  t h e  two  g r o u p s  of p a t i e n t s  in  t h e  a -ke to  a c i d / p l a c e b o  c ross -ove r  t r ia l  
separa te ly .  T h e  u p p e r  p a n e l  c o m b i n e s  t he  da t a  a c c o r d i n g  to s t u d y  per iods .  
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Fig. 5. S e r u m  p r o t e i n  f r ac t i ons  d u r i n g  s t u d y  per iods .  S u p p l e m e n t a t i o n  w i t h  e s sen-  
t ial  a m i n o  ac ids  or  a -ke to  ac ids  c a u s e s  n o  i m p r o v e m e n t  in  a n y  of t h e s e  p a r a m e t e r s .  
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1977 kcal/70 kg). The ingest ion of EAA or a-KA was equivalent  to an 
increase in m e a n  dietary prote in  intake by  a lmost  25 %, to 45.8 or 48 g/ 
70 kg b o d y  weight,  respect ively (fig. 2). The accuracy  of the adherence  to 
the medica t ion  and placebo intake was 82 and  85 %, respectively,  as 
de te rmined  by  count ing  the given and  re turned  dosage. Dur ing  sup- 
plementat ion,  the total ingest ion of high biological value proteins was 
therefore more  than  60 % of the total prote in  intake. Actual  protein inges- 
t ion according  to detailed dietary histories deviated f rom that  prescr ibed 
and dietary counsel ing had little effect on  dietary habits  (fig. 3). Cases with 
the m o s t  m a r k e d  deviat ion in dietary protein intake (such as G.F.) did no t  
affect the overall results of this study. The prote in  intake correlated 
significantly wi th  the urea/creat inine ratio (p < 0.001), i ndependen t  of the 
therapeut ic  phase,  however ,  this correlat ion had  a wide scatter  (r = 0.45). 
Biochemica l  parameters :  Mean values and  s tandard  deviat ions of 
labora tory  data are shown for each s tudy  per iod in table 4. The mean  
creat inine clearance decl ined slightly bu t  not  significantly dur ing  this 
s tudy  (11.81 to 9.6 ml/min/1.73 m 2) (fig. 4) with a cor responding  change  in 
se rum creatinine. Other  values were  abnormal  as expec ted  in renal failure, 
such as elevated blood urea, se rum triglycerides,  ret inol-binding protein 
and  vi tamin A and decreased  hematocr i t  values. Dur ing  different s tudy  
periods, few data gave significant changes  such as serum total prote in  and 
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Fig. 6. Laboratory data during study periods. The decreasing concentrations of 
sodium and calcium with time may be explained by an increased dose of frusemide. 
The phosphorus levels are lowered significantly during keto-acid supplementation. 
Hecking et al., Supplementation with essential amino acids 307 
TRANSFERRIN PArteNrs *~t~ 
g / L  O 9 LOW PROTeIN-INTAKE (~O.55glkgBW.) 
9 =HIGH PROTEIN -iNtAKE 1~0.55g / kgBw.3 
- 5 E M  
9 = 2p~0,05 
, i  9 2p~0.005 
3 .0  
2.0 
Diet 
Fig. 7. Serum transferrin levels for subgroups of 8 and 7 patients with respectively 
lower and higher protein intake. Transferrin levels show no effects by supplementa- 
tion with essential amino acids or a-keto acids, although lower protein intake is 
associated with significantly lower transferrin levels. 
a lbumin  (fig. 5) and se rum sodium,  calcium and  p h o s p h o r u s  concentra-  
t ions (fig. 6). Analysis  of data for subgroups  with h igher  and lower prote in  
intake for parameters  of prote in  def ic iency gave no signif icant  changes  
with the rapy  part icular ly for values in the low normal  range such as C3c 
c o m p l e m e n t  c o m p o n e n t  and t ransferr in  (fig. 7). 
D i s c u s s i o n  
This invest igat ion revealed no beneficial  effects regarding protein defi- 
c iency or renal funct ion fol lowing oral supp lementa t ion  with either EAA 
or a-KA of a 0.57-g/kg-protein diet (approx. 40 g) in cooperat ive outpa- 
t ients wi th  renal  failure. While this s tudy  was no t  pe r fo rmed  on a 
metabol ic  ward,  it a l lowed a pro longed  evaluat ion over  6 weeks  for each 
s tudy  per iod and  the use  of each pat ient  as his own  control. This s tudy  was 
l imited to a very  selected pat ient  popula t ion  whose  renal function,  t hough  
m a r k e d l y  impaired, deter iorated very  s lowly and  who  has r emarkab ly  
cooperat ive regarding weighing  the food, recording  detailed 7-day dietary 
histories repeatedly  and comply ing  well to the prescr ibed supplementa-  
t ion or placebo. The degree of selection is emphas ized  by  the early exclu- 
sion of more  than  50 % of pat ients  who  had  s igned their  consen t  to 
participate. 
Despi te  this selection and  repeated  dietary counseling,  this s tudy  re- 
veals and emphasizes  the l imitations of any  outpat ient  invest igat ion in 
that  dietary prote in  intake deviated f rom that  prescr ibed as shown by  the 
individual  lines in figure 3. On the other  hand,  this f igure also reveals that  
the majori ty  of pat ients  main ta ined  a relatively cons tan t  prote in  intake 
according  to detailed dietary histories. Wirths et al. (29) found  that  dietary 
histories wi thout  we igh ing  the foods wou ld  underes t imate  the prote in  
intake by  an average of 11% and the caloric intake by  15 %. This error  
should  be less in our  pat ients  who  weighed  their  foods. Other  parameters  
for dietary compl iance  such  as ur inary  ni t rogen excret ion or the urea/ 
creatinine ratio are dependen t  on m a n y  other  factors and  are therefore  no t  
very reliable. 
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Renal  funct ion  remained  stable t h roughou t  the 24-week investigation. 
The 5 pat iens who  progressed  to end-stage renal failure were exc luded  
early, 4 of t h e m  before receiving any  supplementa t ion.  Therefore  this 
s tudy  does no t  suppor t  the repor ted  improvemen t  in renal  funct ion dur ing  
a-KA supplementa t ion  (18, 19, 21). The small but  significant decreases in 
serum phosphorus  concent ra t ion  dur ing a-KA therapy  agree with previ- 
ous reports  (21). The observed  reduc t ion  in se rum sodium and calc ium 
concent ra t ion  was p robab ly  due to a gradual ly  increased dose of 
furosemide.  
Our extensive labora tory  invest igat ion before and dur ing supplementa-  
t ion and dur ing  placebo the rapy  revealed only  minor  indicat ions for 
protein def ic iency with relatively low levels of t ransferr in and comple-  
m e n t  C3r componen t .  A subgroup  of 8 patients,  who  restr icted their  pro- 
tein intake to less than  that  prescribed,  had  a significantly lower se rum 
transferr in level than  the  7 patients on a h igher  prote in  intake. This was 
independen t  of therapy,  and renal funct ion did not  differ for the two 
s u b g r o u p s .  This indicates the sensit ivity of this test  and suggests  that  
prote in  deficiency is more  likely to occur  on a protein intake of less than  
0.55 g/kg b o d y  weight.  These  f indings thus  suppor t  the observat ion that  a 
severe dietary prote in  restr ict ion can induce a prote in  deficiency. 
The effect of supp lemen ta t ion  with EAA on parameters  of prote in  
def ic iency revealed a slight but  statistically significant increase in the 
se rum-haptog lob in  concentra t ion.  The fact  that  only one out  of 15 
measured  parameters  reached statistical significance makes  this signifi- 
cance very  quest ionable.  Fur thermore ,  our  studies on EAA supplementa-  
t ion in hemodialys is  pat ients  did not  reveal such an increase in haptoglo- 
bin (25). The double-bl ind trial wi th  a-KA supplementa t ion  indicates 
similarly no beneficial  effect  on  the prote in  state. 
The absence  of clinically impor tan t  benefits  in b iochemical  parameters  
for EAA or a-KA supp lementa t ion  is fur ther  suppor ted  by  an thropomet r ic  
data  which  showed  no improvemen t  dur ing any  s tudy  period. 
We suspect  that  beneficial effects of EAA or a-KA supplementa t ion  are 
l imited to condi t ions  of severe dietary prote in  restr ict ion as d iscussed or 
to catabolic stress in which ni t rogen balance would  become  negat ive (30). 
Since such  severe dietary restr ict ions are poorly  accepted  beyond  short- 
term studies, we chose  to s tudy  EAA or ~-KA supplementa t ion  in patients 
with pre- terminal  renal  failure under  the more  practical  condi t ion  of an 
approximate ly  40-g-protein diet. 
Conclusions:  This s tudy  indicates that  a diet of 0.55 g prote in /kg b o d y  
weight  is not  associated with a definite prote in  deficiency in stable 
ambula to ry  patients wi th  a creatinine clearance in the 10-ml/min range 
and that  for such patients supp lementa t ion  with EAA or a-KA for 6 weeks  
is of no detectable benefi t  and  would  therefore  appear  superfluous.  Since 
severely restr icted prote in  diets of approximate ly  20 g prote in/day have a 
low pat ient  compliance,  we consider  that  such  a strict diet with cost ly 
EAA or a-KA supp lementa t ion  is very  rarely indicated. 
Zusammenfassung 
Art und Zusammensetzung einer optimalen eiwei~armen Ern~hrung f~ir Patien- 
ten mit Niereninsuffizienz sind weiterhin umstritten. Die orale medikamentbse 
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Behandlung mit  essentiellen Arninos~uren oder a-Ketosfiuren wird h~ufig empfoh- 
len. Unsere  Untersuchungen vergleichen nacheinander  bei 15 ambulanten Patien- 
ten mit  chronischem Nierenversagen (mittlere Kreatinin-Clearance 10,8 ml/min) 
unter  einer eiweiBarmen Ern/ihrung yon 0,57 g/kg K6rpergewicht  (40 g/70 kg) die 
Wirkung einer Substi tution mit essentiellen Aminos~uren, danach die Substi tut ion 
mit a-Ketos~uren gegenfiber Plazebo. Der nachgewiesene Proteingehalt  in der 
Nahrung betrug 0,55 g/kg, die Energiezufuhr 27 kcal/kg K6rpergewicht,  wie mehr- 
fach Ern~ihrungsprotokolle tiber jeweils 7 Tage bei den Patienten zeigen lieBen. 
Nach einer Vorperiode yon 6 Wochen nur unter  di~tetischen Ma_Snahmen erhielten 
alle Patienten zus~tzlich 0,112 g essentieUe Aminos~uren/kg KSrpergewicht  fiber 
6 Wochen, danach in einer Doppelbl induntersuchung 0,105 g a-Ketos~uren/kg K6r- 
pergewicht  im Vergleich gegenfiber Plazebo, ebenfalls jeweils fiber 6 Wochen. 
N/~chtern-Blutuntersuchungen wurden far ein Standard-Laborwertprogramm, ins- 
besondere fOr 15 Proteinmangelparameter,  alle 3Wochen  durchgeffihrt, ferner 
anthropometr ische und klinische Kontrollen. Die Laborwerte erbrachten keine 
Hinweise auf einen manifesten Proteinmangel.  Die Therapie mit  ~-Ketos~uren 
erniedrigte die Phosphatspiegel  signifikant (p< 0,05). Dagegen konnten weder  
unter essentiellen Aminos~iuren oder a-Ketos~uren andere ffir den Patienten 
wesentliche Effekte nachgewiesen werden. Deshalb erscheint uns eine Substitu- 
tion mit  essentiellen Aminos~uren oder Ketos~uren tiberfltissig bei Patienten mit 
einer chronischen Niereninsuffizienz, die sich in e inem stabilen Stoffwechsel- 
gleichgewicht befinden und mit  einer EiweiBzufuhr yon 0,55 g/kg K6rpergewicht  
behandelt  werden. 
Abstract  
Oral therapy with essential amino acids (EAA) or a-keto acids (a-KA) has been 
recommended in patients with renal failure, but  quality and quanti ty of optimal 
protein intake are still controversial. This study compares sequentially the effect of 
supplementat ion with EAA, and with a-KA versus placebo in 15 ambulatory 
patients with chronic renal failure (average creatinine clearance 10.8 ml/min), main- 
tained on a protein diet of 0.57 g]kg body weight  (40 g for a 70-kg patient). The actual 
dietary intake averaged 0.55 g protein/kg and 27 kcal/kg according to repeated 7- 
day dietary recordings. After a 6-week baseline period on this diet, all patients 
received additionally 0.112 g EAA/kg for 6 weeks followed by a double-blind cross- 
over study of 0.105 g a-KA/kg versus placebo supplementat ion for 6 weeks each. 
Fasting blood samples for multiple parameters, including 15 indicators for protein 
deficiency, as well as anthropometr ic  and clinical data were evaluated every 
3 weeks. Laboratory data revealed no indications of protein deficiency. Therapy 
with a-KA diminished serum phosphate concentration (p < 0.05), however  no other 
significant beneficial effects could be demonstrated during supplementat ion with 
either EAA or a-KA. Therefore, such supplementat ion to a 0.55-g/kg-protein diet 
appears superfluous in stable ambulatory patients with renal insufficiency. 
K e y  words: chronic renal failure, dietary treatment,  essential amino acids, a-keto 
acids, nutrition 
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